BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36435048)

  • 21. Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population.
    Hlavacek P; Guo JD; Rosenblatt L; Keshishian A; Russ C; Mardekian J; Ferri M; Poretta T; Yuce H; McBane R
    Curr Med Res Opin; 2019 Dec; 35(12):2043-2051. PubMed ID: 31387467
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study.
    Piran S; Schulman S
    Thromb Res; 2016 Nov; 147():97-101. PubMed ID: 27721141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
    Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.
    Stiller CA; Passmore SJ; Kroll ME; Brownbill PA; Wallis JC; Craft AW
    Br J Cancer; 2006 Jan; 94(1):22-9. PubMed ID: 16317433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden.
    Balabanova Y; Farahmand B; Stattin P; Garmo H; Brobert G
    BMC Urol; 2022 Feb; 22(1):15. PubMed ID: 35109829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study.
    Bang SM; Kang JH; Hong MH; Ahn JS; Oh SY; Baek JH; Choi YJ; Shin SH; Kim YJ; Gil HY; Park HE; Lee J; Park EL
    Clin Appl Thromb Hemost; 2021; 27():1076029620979575. PubMed ID: 33471574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives.
    Fleuren ED; Versleijen-Jonkers YM; Boerman OC; van der Graaf WT
    Biochim Biophys Acta; 2014 Apr; 1845(2):266-76. PubMed ID: 24582852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
    Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Societal costs of venous thromboembolism and subsequent major bleeding events: a national register-based study.
    Gustafsson N; Poulsen PB; Stallknecht SE; Dybro L; Paaske Johnsen S
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):130-137. PubMed ID: 31287536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study.
    Roberts MZ; Gaskill GE; Kanter-Washko J; Kyle TR; Jones BC; Bohm NM
    J Thromb Thrombolysis; 2018 May; 45(4):512-515. PubMed ID: 29556958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis.
    Mai V; Tanguay VF; Guay CA; Bertoletti L; Magnan S; Turgeon AF; Lacasse Y; Lega JC; Provencher S
    J Thromb Thrombolysis; 2020 Oct; 50(3):661-667. PubMed ID: 32052314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.
    Groot OQ; Ogink PT; Janssen SJ; Paulino Pereira NR; Lozano-Calderon S; Raskin K; Hornicek F; Schwab JH
    Clin Orthop Relat Res; 2018 Oct; 476(10):2052-2061. PubMed ID: 30179923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
    Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
    Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
    Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolism.
    Kelley D; Wright L; Ohman K; Ferreira J
    J Thromb Thrombolysis; 2018 Jul; 46(1):58-61. PubMed ID: 29797208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk and complications of venous thromboembolism in dialysis patients.
    Molnar AO; Bota SE; McArthur E; Lam NN; Garg AX; Wald R; Zimmerman D; Sood MM
    Nephrol Dial Transplant; 2018 May; 33(5):874-880. PubMed ID: 28992258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.